AGRP, agouti related neuropeptide, 181

N. diseases: 233; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028754
Disease: Obesity
Obesity
0.700 Biomarker disease CTD_human
CUI: C0028754
Disease: Obesity
Obesity
0.700 Biomarker disease HPO
CUI: C0039870
Disease: Thinness
Thinness
0.100 CausalMutation phenotype CLINVAR
CUI: C4016782
Disease: OBESITY, LATE-ONSET
OBESITY, LATE-ONSET
0.100 GeneticVariation phenotype CLINVAR
Decreased resting energy expenditure
0.100 Biomarker phenotype HPO
CUI: C4703554
Disease: Increased waist to hip ratio
Increased waist to hip ratio
0.100 Biomarker phenotype HPO
CUI: C0023493
Disease: Adult T-Cell Lymphoma/Leukemia
Adult T-Cell Lymphoma/Leukemia
0.010 Biomarker disease BEFREE ADF also enhanced IL 2-R expression of a rat T cell line transformed by HTLV-1(TARS-1), as demonstrated with anti-rat IL 2 receptor monoclonal antibodies (ART-18). 2999237 1985
CUI: C0023467
Disease: Leukemia, Myelocytic, Acute
Leukemia, Myelocytic, Acute
0.010 GeneticVariation disease BEFREE A novel variant of the chimerical MLL-AF10 mRNA transcript was detected in a pediatric patient with acute myeloid leukemia (AML) by a new asymmetric reverse-transcription polymerase chain reaction (ART-PCR) method. 9305618 1997
CUI: C0028754
Disease: Obesity
Obesity
0.700 AlteredExpression disease BEFREE Ubiquitous expression of human AGRP complementary DNA in transgenic mice caused obesity without altering pigmentation. 9311920 1997
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.060 GeneticVariation group BEFREE With this in mind, and recent advances in state of the art gene delivery system coupled with the anticipated completion of the human genome project, it is timely to think about the possibility of treating and/or curing hypertension using genetic means. 10779083 2000
CUI: C0028754
Disease: Obesity
Obesity
0.700 GeneticVariation disease BEFREE This variable expressivity of MC4-R-associated obesity is not due to variations in genes for alpha-MSH or AGRP. 10903341 2000
CUI: C0020505
Disease: Hyperphagia
Hyperphagia
0.200 Biomarker phenotype RGD Rats rendered diabetic by streptozotocin displayed marked hyperglycemia (blood glucose 456.0+/-8.4 mg/dl versus 71.8+/-1.9 mg/dl) and hyperphagia (36.9+/-1.0 g/day versus 22.0+/-0.4 g/day), that was associated with a 286.6+/-4.4% increase in hypothalamic AGRP mRNA and a 178.9+/-13.5% increase in hypothalamic NPY mRNA. 11179781 2001
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.070 GeneticVariation disease BEFREE These data indicate that variations of AGRP are associated with susceptibility for AN. 11326303 2001
CUI: C0028754
Disease: Obesity
Obesity
0.700 GeneticVariation disease BEFREE Mutations in AGRP and alpha MSH genes were not among the causes of obesity in our population. 11487744 2001
CUI: C0028756
Disease: Obesity, Morbid
Obesity, Morbid
0.030 Biomarker disease BEFREE To search for mutations in melanocortin pathway elements, that is, the melanocortin-4 receptor (MC4R ), agouti-related protein (AGRP ), and (alpha-melanocyte-stimulating hormone (alpha MSH ) genes in children with severe obesity. 11487744 2001
CUI: C0028754
Disease: Obesity
Obesity
0.700 Biomarker disease BEFREE A role for the Agouti-Related Protein promoter in obesity and type 2 diabetes. 11554767 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.210 Biomarker disease BEFREE A role for the Agouti-Related Protein promoter in obesity and type 2 diabetes. 11554767 2001
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.070 GeneticVariation disease BEFREE One variant of the AgRP gene was associated with anorexia nervosa, thus putting forward melanocortin receptor blockade as putative pharmacotherapy. 11704425 2001
CUI: C0032897
Disease: Prader-Willi Syndrome
Prader-Willi Syndrome
0.010 Biomarker disease BEFREE Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. 11836343 2002
CUI: C0036220
Disease: Kaposi Sarcoma
Kaposi Sarcoma
0.040 Biomarker disease BEFREE RTA (replication and transcription activator; also referred to as ORF50, Lyta, and ART), an immediate-early gene product of Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8, disrupts latency and drives lytic replication. 11967316 2002
CUI: C0028754
Disease: Obesity
Obesity
0.700 GeneticVariation disease BEFREE The c.199G-->A polymorphism in hAGRP could, therefore, play a role in the development of human obesity in an age-dependent fashion. 12213871 2002
CUI: C0024535
Disease: Malaria, Falciparum
Malaria, Falciparum
0.010 Biomarker disease BEFREE We recently found artesunate plus sulfadoxine-pyrimethamine (ART-SP) to be highly effective (96%) in the treatment of falciparum malaria in Papua Province. 12435700 2002
CUI: C0026847
Disease: Spinal Muscular Atrophy
Spinal Muscular Atrophy
0.010 Biomarker disease BEFREE Private ART laboratory.Two couples undergoing IVF for infertility therapy, both of whom had previously delivered offspring afflicted with spinal muscular atrophy (type 1) after IVF therapy, and who underwent subsequent cycles of IVF coupled with PGD to screen for this disorder. 12909515 2003
CUI: C0028754
Disease: Obesity
Obesity
0.700 Biomarker disease BEFREE The currently available data suggest that elevated AGRP mRNA along with reduced proopiomelanocortin (POMC) mRNA is associated with many types of obesity and agents antagonizing the effect of AGRP may be a potential therapeutic target in treating obesity and obesity-associated disorders in which endogenous hypothalamic AGRP is elevated. 14572167 2003
CUI: C4087436
Disease: HIV viraemia
HIV viraemia
0.030 Biomarker disease BEFREE We previously demonstrated that short-cycle structured intermittent therapy (SIT; 7 days without therapy followed by 7 days with antiretroviral therapy [ART]) with a ritonavir-boosted, indinavir-based, twice-daily regimen maintained suppression of plasma HIV viremia while reducing serum levels of lipids. 15143462 2004